The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019).


Journal

Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137

Informations de publication

Date de publication:
10 2020
Historique:
received: 02 04 2020
accepted: 06 08 2020
pubmed: 18 8 2020
medline: 9 10 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

Primary immunodeficiencies (PIDs) are heterogeneous disorders, characterized by variable clinical and immunological features. National PID registries offer useful insights on the epidemiology, diagnosis, and natural history of these disorders. In 1999, the Italian network for primary immunodeficiencies (IPINet) was established. We report on data collected from the IPINet registry after 20 years of activity. A total of 3352 pediatric and adult patients affected with PIDs are registered in the database. In Italy, a regional distribution trend of PID diagnosis was observed. Based on the updated IUIS classification of 2019, PID distribution in Italy showed that predominantly antibody deficiencies account for the majority of cases (63%), followed by combined immunodeficiencies with associated or syndromic features (22.5%). The overall age at diagnosis was younger for male patients. The minimal prevalence of PIDs in Italy resulted in 5.1 per 100.000 habitants. Mortality was similar to other European registries (4.2%). Immunoglobulin replacement treatment was prescribed to less than one third of the patient cohort. Collectively, this is the first comprehensive description of the PID epidemiology in Italy.

Identifiants

pubmed: 32803625
doi: 10.1007/s10875-020-00844-0
pii: 10.1007/s10875-020-00844-0
pmc: PMC7505879
doi:

Types de publication

Historical Article Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1026-1037

Références

J Clin Immunol. 2007 Sep;27(5):517-24
pubmed: 17588141
Front Immunol. 2019 Jul 19;10:1272
pubmed: 31379802
J Clin Immunol. 1997 Jul;17(4):333-9
pubmed: 9258772
Isr Med Assoc J. 2002 Nov;4(11 Suppl):868-71
pubmed: 12455164
Clin Exp Immunol. 2018 Jun;192(3):284-291
pubmed: 29878323
Front Immunol. 2019 Jul 24;10:1754
pubmed: 31396239
J Clin Immunol. 2015 Nov;35(8):745-53
pubmed: 26464197
J Clin Immunol. 2020 Jan;40(1):66-81
pubmed: 32048120
Adv Exp Med Biol. 2017;1031:3-21
pubmed: 29214563
J Clin Immunol. 2016 Nov;36(8):764-773
pubmed: 27582173
Pediatrics. 2019 Feb;143(2):
pubmed: 30683812
Ann Ist Super Sanita. 2019 Jul-Sep;55(3):296-304
pubmed: 31553326
Clin Exp Immunol. 2015 Oct;182(1):45-50
pubmed: 26031847
J Clin Immunol. 2020 Jan;40(1):24-64
pubmed: 31953710
J Clin Immunol. 2000 Nov;20(6):477-85
pubmed: 11202238
J Clin Immunol. 2015 Jan;35(1):75-9
pubmed: 25315263
Clin Immunol. 2010 May;135(2):264-72
pubmed: 20399414
J Clin Immunol. 2005 Jan;25(1):73-7
pubmed: 15742160
J Clin Immunol. 2014 May;34(4):459-68
pubmed: 24619622
Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S35-8
pubmed: 18545242
Clin Immunol. 2015 Feb;156(2):154-62
pubmed: 25451158

Auteurs

Vassilios Lougaris (V)

Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy. vlougarisbs@yahoo.com.

Andrea Pession (A)

Unit of Pediatrics, University of Bologna, St. Orsola University Hospital, Bologna, Italy.

Manuela Baronio (M)

Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Annarosa Soresina (A)

Pediatrics Clinic, ASST- Spedali Civili of Brescia, Brescia, Italy.

Roberto Rondelli (R)

Unit of Pediatrics, University of Bologna, St. Orsola University Hospital, Bologna, Italy.

Luisa Gazzurelli (L)

Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Alessio Benvenuto (A)

Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Silvana Martino (S)

Division of Pediatric Immunology and Rheumatology, Department of Public Health and Pediatrics, "Regina Margherita" Children Hospital, University of Turin, Turin, Italy.

Marco Gattorno (M)

Centro Malattie Autoinfiammatorie e Immunodeficienze- IRCCS Giannina Gaslini, Via Gaslini 5, 16147, Genoa, Italy.

Andrea Biondi (A)

Clinica Pediatrica, MBBM Foundation, University of Milano-Bicocca, Monza, Italy.

Marco Zecca (M)

Department of Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Maddalena Marinoni (M)

Paediatric Department, ASST-Sette Laghi, "F. Del Ponte" Hospital, Varese, Italy.

Giovanna Fabio (G)

Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Alessandro Aiuti (A)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Paediatric Immunohematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vita Salute San Raffaele University, Milan, Italy.

Gianluigi Marseglia (G)

Department of Pediatrics, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

Maria Caterina Putti (MC)

Department of Women's and Children's Health, Pediatric Hematology-Oncology Unit, University of Padova, Padova, Italy.

Carlo Agostini (C)

Center for Immunologic, Rheumatologic and Respiratory Diseases, Ca' Foncello Hospital, Treviso, Italy.

Claudio Lunardi (C)

Department of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.

Alberto Tommasini (A)

Department of Paediatrics, Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Trieste, Italy.
Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.

Patrizia Bertolini (P)

Paediatric Hematology Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.

Eleonora Gambineri (E)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Rita Consolini (R)

Section of Pediatrics Immunology and Rheumatology, Department of Pediatrics, University of Pisa, Pisa, Italy.

Andrea Matucci (A)

Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy.

Chiara Azzari (C)

Department of Pediatric Immunology, Jeffrey Modell Center for Primary Immunodeficiency, Anna Meyer's Hospital, University of Florence, Florence, Italy.

Maria Giovanna Danieli (MG)

Clinica Medica, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche e Azienda Ospedali Riuniti, Ancona, Italy.

Roberto Paganelli (R)

Section of Traslational Medicine, Department of Medicine and Sciences of Aging, G. d'Annunzio University, Chieti, Italy.

Marzia Duse (M)

Pediatrics Department, Umberto I Hospital, Rome, Italy.
Sapienza University, Rome, Italy.

Caterina Cancrini (C)

Unit of Immunology and Infectious Diseases, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Rome, Italy.

Viviana Moschese (V)

Department of Pediatrics, Policlinico Tor Vergata, Tor Vergata University, Rome, Italy.

Luciana Chessa (L)

Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.

Giuseppe Spadaro (G)

Department of Translational Medical Sciences, Allergy and Clinical Immunology Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.

Adele Civino (A)

Ospedale Vito Fazzi, Lecce, Italy.

Angelo Vacca (A)

Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.

Fabio Cardinale (F)

Department of Pediatrics and Emergency, Pediatric Allergy and Pulmunology Unit, Azienda Ospedaliera-Universitaria "Consorziale-Policlinico", Ospedale Pediatrico Giovanni XXIII, Bari, Italy.

Baldassare Martire (B)

Pediatric Unit, "Monsignor Dimiccoli" Hospital, Barletta, Italy.

Luigi Carpino (L)

Pediatrics Unit, "Annunziata" Hospital, Cosenza, Italy.

Antonino Trizzino (A)

Department of Pediatric Hematology and Oncology, ARNAS Civico Di Cristina and Benfratelli Hospital, Palermo, Italy.

Giovanna Russo (G)

Haematology/Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Fausto Cossu (F)

2nd Pediatric Clinic, Antonio Cao Hospital, University of Cagliari, Cagliari, Italy.

Raffaele Badolato (R)

Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Maria Cristina Pietrogrande (MC)

Department of Pediatrics, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

Isabella Quinti (I)

Department of Molecular Medicine, Sapienza University, Rome, Italy.

Paolo Rossi (P)

Unit of Immunology and Infectious Diseases, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Rome, Italy.

Alberto Ugazio (A)

Institute of Child and Adolescent Health, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Claudio Pignata (C)

Pediatric Section, Department of Translational Medical Science, Federico II University, Naples, Italy.

Alessandro Plebani (A)

Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH